Q2867071 (Q2867071): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Created claim: summary (P836): The TERAPI4 project aims to protect the intellectual property rights of a new class of therapeutic agents against rare amyloid transthyretin diseases. These new compounds are small molecules belonging to the NT60 chemical series developed by BSIM Therapeutics., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
The TERAPI4 project aims to protect the intellectual property rights of a new class of therapeutic agents against rare amyloid transthyretin diseases. These new compounds are small molecules belonging to the NT60 chemical series developed by BSIM Therapeutics. (English) | |||||||||||||||
| Property / summary: The TERAPI4 project aims to protect the intellectual property rights of a new class of therapeutic agents against rare amyloid transthyretin diseases. These new compounds are small molecules belonging to the NT60 chemical series developed by BSIM Therapeutics. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The TERAPI4 project aims to protect the intellectual property rights of a new class of therapeutic agents against rare amyloid transthyretin diseases. These new compounds are small molecules belonging to the NT60 chemical series developed by BSIM Therapeutics. (English) / qualifier | |||||||||||||||
point in time: 7 July 2021
| |||||||||||||||
Revision as of 01:11, 7 July 2021
Project Q2867071 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q2867071 in Portugal |
Statements
25,000.0 Euro
0 references
76.0 percent
0 references
1 April 2020
0 references
1 April 2023
0 references
BSIM THERAPEUTICS, S.A.
0 references
40°12'40.28"N, 8°25'46.06"W
0 references
O projeto TERAPI4 visa a proteção dos direitos de Propriedade Intelectual de uma nova classe de agentes terapêuticos contra doenças amiloides raras de transtirretina. Estes novos compostos são pequenas moléculas pertencentes à série química NT60 desenvolvida pela BSIM Therapeutics. (Portuguese)
0 references
The TERAPI4 project aims to protect the intellectual property rights of a new class of therapeutic agents against rare amyloid transthyretin diseases. These new compounds are small molecules belonging to the NT60 chemical series developed by BSIM Therapeutics. (English)
7 July 2021
0 references
Coimbra
0 references
Identifiers
CENTRO-01-0247-FEDER-046897
0 references